BDBM327779 US9663475, Compound A1::US9663475, Compound A2

SMILES NC1=Nc2ccccc2CN1C1Cc2ccccc2C1

InChI Key InChIKey=LUIUXEPEGXGALG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 327779   

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327779(US9663475, Compound A1 | US9663475, Compound A2)
Affinity DataIC50: 2.30E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327779(US9663475, Compound A1 | US9663475, Compound A2)
Affinity DataIC50: 2.70E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
US Patent